loadpatents
Patent applications and USPTO patent grants for Rice; Lyndi M..The latest application filed is for "sirna targeting ets1 and elk1 and method of using same in the inhibition of cip2a gene in cancer treatment".
Patent | Date |
---|---|
PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition Grant 9,663,789 - Rice , et al. May 30, 2 | 2017-05-30 |
SiRNA TARGETING ETS1 AND ELK1 AND METHOD OF USING SAME IN THE INHIBITION OF CIP2A GENE IN CANCER TREATMENT App 20160082034 - Rice; Lyndi M. ;   et al. | 2016-03-24 |
Pme-1 As A Biomarker To Predict And Diagnose Endometrial And Breast Cancer And Gene Silencing Of Pme-1 To Inhibit Epithelial To Mesenchymal Transition App 20150284723 - Rice; Lyndi M. ;   et al. | 2015-10-08 |
SiRNA targeting ETS1 and ELK1 and method of using same in the inhibition of CIP2A gene in cancer treatment Grant 9,139,829 - Rice , et al. September 22, 2 | 2015-09-22 |
SiRNA TARGETING ETS1 AND ELK1 AND METHOD OF USING SAME IN THE INHIBITION OF CIP2A GENE IN CANCER TREATMENT App 20130225657 - Rice; Lyndi M. ;   et al. | 2013-08-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.